Valeant Short Sellers Net 343% Profit As Eyes Turn To John PaulsonMark Melin
As Bill Ackman and Pershing Square Capital Management are licking their recent wounds due to well-publicized trades in Herbalife Ltd. (NYSE:HLF) and Valeant Pharmaceuticals (NYSE:VRX), there are winners as well as losers. As short sellers count their profits, and gradually reduce their exposure, they eye hedge fund manager John Paulson, whose Paulson & Company is still long the stock, for a squeeze opportunity.
Ackman's . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.